نمایش مختصر رکورد

dc.contributor.authorHaydari, Mohammad Rezaen_US
dc.contributor.authorPanjeshahin, Mohammad Rezaen_US
dc.contributor.authorMashghoolozekr, Elahehen_US
dc.contributor.authorNekooeian, Ali Akbaren_US
dc.date.accessioned1399-07-30T21:00:10Zfa_IR
dc.date.accessioned2020-10-21T21:00:10Z
dc.date.available1399-07-30T21:00:10Zfa_IR
dc.date.available2020-10-21T21:00:10Z
dc.date.issued2017-05-01en_US
dc.date.issued1396-02-11fa_IR
dc.date.submitted2016-03-15en_US
dc.date.submitted1394-12-25fa_IR
dc.identifier.citationHaydari, Mohammad Reza, Panjeshahin, Mohammad Reza, Mashghoolozekr, Elaheh, Nekooeian, Ali Akbar. (2017). Antihypertensive Effects of Hydroalcoholic Extract of Crataegus Azarolus Subspecies Aronia Fruit in Rats with Renovascular Hypertension: An Experimental Mechanistic Study. Iranian Journal of Medical Sciences, 42(3), 266-274.en_US
dc.identifier.issn0253-0716
dc.identifier.issn1735-3688
dc.identifier.urihttps://ijms.sums.ac.ir/article_40453.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/439823
dc.description.abstractBackground: Hawthorn species decreases blood pressure and relaxes precontracted vessels. This study aimed at examining the antihypertensive effect and related mechanisms of hydroalcoholic extract of Crataegus azarolus subspecies aronia fruit in rats with renovascular hypertension.Methods: Six groups of male Sprague-Dawley rats, each containing 6 to 8 rats, were studied. The groups comprised of one sham group and 5 renal artery-clipped groups. The sham group received vehicle (distilled water 0.5 ml/day) and the renal artery-clipped groups received vehicle or the extract at 5, 10, 20 or 30 mg/kg/day. Oral vehicle or extract was administered daily for 4 weeks following sham-operation or induction of hypertension. Systolic blood pressure and heart rate were measured weekly. Isolated aorta study was performed by last week and serum superoxide dismutase and glutathione reductase were measured. The findings were analyzed using one-way analysis of variance and Duncan’s multiple range tests at P≤0.05 using SigmaStat software.Results: The data obtained after 4 weeks of treatment showed that the renal artery-clipped group receiving vehicle had significantly higher systolic blood pressure (P=0.002) and phenylephrine maximal response (P=0.01); and lower acetylcholine maximal response (P=0.01), serum superoxide dismutase (P=0.006) and serum glutathione reductase (P=0.006) than those of the sham group. The renal artery-clipped group receiving extract had significantly lower systolic blood pressure (P=0.03) and phenylephrine maximal response (P=0.01); and significantly higher acetylcholine maximal response (P=0.01), serum superoxide dismutase (P=0.015), and serum glutathione reductase (P=0.015) than those of the renal artery-clipped group receiving vehicle.Conclusion: Our findings show that the hydroalcoholic extract of Crataegus azarolus subspecies aronia fruit has antihypertensive effects, which may be partly due to antioxidant and nitric oxide releasing effects.en_US
dc.languageEnglish
dc.language.isoen_US
dc.publisherShiraz University of Medical Sciencesen_US
dc.relation.ispartofIranian Journal of Medical Sciencesen_US
dc.subjectCrataegusen_US
dc.subjectRenovascularen_US
dc.subjectNitric oxideen_US
dc.subjectOxidative stressen_US
dc.subjectHypertensionen_US
dc.titleAntihypertensive Effects of Hydroalcoholic Extract of Crataegus Azarolus Subspecies Aronia Fruit in Rats with Renovascular Hypertension: An Experimental Mechanistic Studyen_US
dc.typeTexten_US
dc.typeOriginal Article(s)en_US
dc.contributor.departmentCardiovascular Pharmacology Research Lab, Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; and Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iranen_US
dc.contributor.departmentCardiovascular Pharmacology Research Lab, Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iranen_US
dc.contributor.departmentCardiovascular Pharmacology Research Lab, Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; and Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iranen_US
dc.contributor.departmentCardiovascular Pharmacology Research Lab, Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; and Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iranen_US
dc.citation.volume42
dc.citation.issue3
dc.citation.spage266
dc.citation.epage274


فایل‌های این مورد

فایل‌هااندازهقالبمشاهده

فایلی با این مورد مرتبط نشده است.

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد